Actelion Pharmaceuticals Ltd - Company Profile
Powered by
All the data and insights you need on Actelion Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Actelion Pharmaceuticals Ltd Strategy Report
- Understand Actelion Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Actelion Pharmaceuticals Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
15 Sep 2021 | Owkin Enters into Agreement with Actelion Pharma | Partnership | - |
Owkin Inc
Actelion Pharmaceuticals Ltd |
02 Mar 2021 | Beyond Batten Disease Foundation Enters into Agreement with Actelion Pharma | Partnership | - |
Actelion Pharmaceuticals Ltd
Beyond Batten Disease Foundation
|
05 Jan 2021 | Actelion Pharmaceuticals Ltd Enters Phase IV Clinical Trial Agreement with IQVIA Holdings Inc for selexipag (GDCT0390838) | Contract Service Agreement |
Actelion Pharmaceuticals Ltd
|
IQVIA Holdings Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer